{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,10]],"date-time":"2026-07-10T07:05:16Z","timestamp":1783667116245,"version":"3.55.0"},"reference-count":48,"publisher":"Oxford University Press (OUP)","issue":"Supplement_1","license":[{"start":{"date-parts":[[2026,1,30]],"date-time":"2026-01-30T00:00:00Z","timestamp":1769731200000},"content-version":"vor","delay-in-days":29,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,1,30]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Arrhythmic sudden cardiac death (SCD) remains a major cause of late mortality in adults with congenital heart disease (ACHD), second only to heart failure. Risk prediction is challenging due to the heterogeneity of underlying defects and surgical histories. This review summarizes contemporary evidence on arrhythmic SCD prevention in ACHD, focusing on lesion-specific risk stratification, device-based therapies, and emerging technologies. Traditional markers\u2014ventricular dysfunction, QRS prolongation, and prior arrhythmias\u2014show limited predictive value. Recent models such as PREVENTION-ACHD and the Spanish ACHD Network score offer structured but evolving approaches to individualized risk assessment. Cardiac MRI-derived fibrosis quantification, electro-anatomical mapping, and machine-learning\u2013based tools hold promise for refined prediction. Implantable cardioverter-defibrillators (ICDs) remain the cornerstone of secondary prevention, while subcutaneous ICDs and emerging extravascular systems mitigate lead-related complications. The wearable cardioverter-defibrillator offers a temporary protective option in high-risk patients awaiting definitive therapy. Catheter ablation\u2014particularly in repaired Tetralogy of Fallot\u2014can modify arrhythmic substrates, whereas bradyarrhythmias require vigilant monitoring and timely pacing interventions. In conclusion, effective prevention of arrhythmic SCD in ACHD demands a multidisciplinary, lesion-specific approach integrating advanced imaging, device innovation, and personalized risk modelling. Ongoing refinement of predictive tools and interventional strategies will be crucial to reduce mortality in this growing population.<\/jats:p>","DOI":"10.1093\/eurheartjsupp\/suaf090","type":"journal-article","created":{"date-parts":[[2025,11,5]],"date-time":"2025-11-05T13:36:25Z","timestamp":1762349785000},"page":"i25-i32","source":"Crossref","is-referenced-by-count":4,"title":["Strategies for preventing arrhythmic sudden death in adult congenital heart disease"],"prefix":"10.1093","volume":"28","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9941-8500","authenticated-orcid":false,"given":"Berardo","family":"Sarubbi","sequence":"first","affiliation":[{"name":"Adult Congenital Heart Disease Unit, Monaldi Hospital , Naples \u00a0","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Victor","family":"Waldmann","sequence":"additional","affiliation":[{"name":"Unit\u00e9 M\u00e9dico-Chirurgicale de Cardiologie Cong\u00e9nitale Adulte, H\u00f4pital Europeen Georges Pompidou , Paris ,","place":["France"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giovanni Domenico","family":"Ciriello","sequence":"additional","affiliation":[{"name":"Adult Congenital Heart Disease Unit, Monaldi Hospital , Naples \u00a0","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6484-4961","authenticated-orcid":false,"given":"Tom","family":"Wong","sequence":"additional","affiliation":[{"name":"Heart Rhythm Centre, Royal Brompton and Harefield Hospitals, Guy\u2019s and St. Thomas\u2019 NHS Foundation Trust , London ,","place":["UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u00d3scar","family":"Cano","sequence":"additional","affiliation":[{"name":"Hospital Universitari I Polit\u00e8cnic La Fe and Centro de Investigaciones Biom\u00e9dicas en RED en Enfermedades Cardiovasculares (CIBERCV) , Valencia ,","place":["Spain"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2026,1,30]]},"reference":[{"key":"2026012919022683600_suaf090-B1","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1093\/eurheartj\/ehaa554","article-title":"2020 ESC guidelines for the management of adult congenital heart disease","volume":"42","author":"Baumgartner","year":"2021","journal-title":"Eur Heart J"},{"key":"2026012919022683600_suaf090-B2","doi-asserted-by":"crossref","first-page":"1719","DOI":"10.1093\/europace\/eux380","article-title":"Arrhythmias in congenital heart disease: a position paper of the European Heart Rhythm Association (EHRA), Association for European Paediatric and Congenital Cardiology (AEPC), and the European Society of Cardiology (ESC) working group on grown-up congenital heart disease, endorsed by HRS, PACES, APHRS, and SOLAECE","volume":"20","author":"Hern\u00e1ndez-Madrid","year":"2018","journal-title":"Europace"},{"key":"2026012919022683600_suaf090-B3","doi-asserted-by":"crossref","first-page":"3997","DOI":"10.1093\/eurheartj\/ehac262","article-title":"2022 ESC guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death","volume":"43","author":"Zeppenfeld","year":"2022","journal-title":"Eur Heart J"},{"key":"2026012919022683600_suaf090-B4","doi-asserted-by":"crossref","first-page":"1735","DOI":"10.1016\/j.hrthm.2014.07.021","article-title":"Sudden death in adult congenital heart disease: risk stratification in 2014","volume":"11","author":"Walsh","year":"2014","journal-title":"Heart Rhythm"},{"key":"2026012919022683600_suaf090-B5","first-page":"401","article-title":"Sudden cardiac death in adult congenital heart disease: can the unpredictable be foreseen?","volume":"19","author":"Koyak","year":"2017","journal-title":"Europace"},{"key":"2026012919022683600_suaf090-B6","first-page":"401","article-title":"Current state of risk stratification for sudden cardiac death in adults with congenital heart disease","volume":"19","author":"Vehmeijer","year":"2018","journal-title":"Anatol J Cardiol"},{"key":"2026012919022683600_suaf090-B7","doi-asserted-by":"crossref","first-page":"2103","DOI":"10.1093\/eurheartj\/ehac104","article-title":"Sudden cardiac death in congenital heart disease","volume":"43","author":"Khairy","year":"2022","journal-title":"Eur Heart J"},{"key":"2026012919022683600_suaf090-B8","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1161\/01.CIR.92.2.231","article-title":"Mechanoelectrical interaction in tetralogy of Fallot. QRS prolongation relates to right ventricular size and predicts malignant ventricular arrhythmias and sudden death","volume":"92","author":"Gatzoulis","year":"1995","journal-title":"Circulation"},{"key":"2026012919022683600_suaf090-B9","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1161\/CIRCULATIONAHA.105.548727","article-title":"Ventricular fibrosis suggested by cardiovascular magnetic resonance in adults with repaired tetralogy of Fallot and its relationship to adverse markers of clinical outcome","volume":"113","author":"Babu-Narayan","year":"2006","journal-title":"Circulation"},{"key":"2026012919022683600_suaf090-B10","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.1586\/erc.09.153","article-title":"Sudden cardiac death in adults with congenital heart disease","volume":"7","author":"Yap","year":"2009","journal-title":"Expert Rev Cardiovasc Ther"},{"key":"2026012919022683600_suaf090-B11","doi-asserted-by":"crossref","first-page":"2685","DOI":"10.1093\/eurheartj\/ehac288","article-title":"A new score for life-threatening ventricular arrhythmias and sudden cardiac death in adults with transposition of the great arteries and a systemic right ventricle","volume":"43","author":"Ladouceur","year":"2022","journal-title":"Eur Heart J"},{"key":"2026012919022683600_suaf090-B12","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1016\/j.jacc.2022.06.020","article-title":"Long-term outcomes after atrial switch operation for transposition of the great arteries","volume":"80","author":"Broberg","year":"2022","journal-title":"J Am Coll Cardiol"},{"key":"2026012919022683600_suaf090-B13","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1136\/hrt.67.1.72","article-title":"Early and late arrhythmias after the Fontan operation: predisposing factors and clinical consequences","volume":"67","author":"Gewillig","year":"1992","journal-title":"Br Heart J"},{"key":"2026012919022683600_suaf090-B14","doi-asserted-by":"crossref","first-page":"1468","DOI":"10.1016\/j.amjcard.2017.01.018","article-title":"Outcomes of direct current cardioversion in adults with congenital heart disease","volume":"119","author":"Egbe","year":"2017","journal-title":"Am J Cardiol"},{"key":"2026012919022683600_suaf090-B15","doi-asserted-by":"crossref","first-page":"1933","DOI":"10.1093\/eurheartj\/ehaf137","article-title":"The Fontan adult Brompton clinical score and mortality risk","volume":"46","author":"Montanaro","year":"2025","journal-title":"Eur Heart J"},{"key":"2026012919022683600_suaf090-B16","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1016\/j.hrthm.2021.01.009","article-title":"Identification of patients at risk of sudden cardiac death in congenital heart disease: the PRospEctiVE study on implaNTable cardIOverter defibrillator therapy and suddeN cardiac death in adults with congenital heart disease (PREVENTION-ACHD)","volume":"18","author":"Vehmeijer","year":"2021","journal-title":"Heart Rhythm"},{"key":"2026012919022683600_suaf090-B17","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1136\/heartjnl-2020-316791","article-title":"Predicting sudden cardiac death in adults with congenital heart disease","volume":"107","author":"Oliver","year":"2021","journal-title":"Heart"},{"key":"2026012919022683600_suaf090-B18","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.ahj.2021.11.015","article-title":"Cardiac MRI predictors of good long-term outcomes in patients with repaired TOF","volume":"245","author":"Majeed","year":"2022","journal-title":"Am Heart J"},{"key":"2026012919022683600_suaf090-B19","doi-asserted-by":"crossref","first-page":"2613","DOI":"10.1016\/j.jacep.2024.07.016","article-title":"Ventricular tachycardia substrates in children and young adults with repaired tetralogy of Fallot","volume":"10","author":"Wallet","year":"2024","journal-title":"JACC Clin Electrophysiol"},{"key":"2026012919022683600_suaf090-B20","doi-asserted-by":"crossref","first-page":"965204","DOI":"10.3389\/fped.2022.965204","article-title":"Myocardial fibrosis in congenital heart disease","volume":"10","author":"Gordon","year":"2022","journal-title":"Front Pediatr"},{"key":"2026012919022683600_suaf090-B21","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1136\/heartjnl-2023-323296","article-title":"Incremental value of machine learning for risk prediction in tetralogy of Fallot","volume":"110","author":"Ishikita","year":"2024","journal-title":"Heart"},{"key":"2026012919022683600_suaf090-B22","doi-asserted-by":"crossref","first-page":"1678","DOI":"10.1136\/heartjnl-2017-312777","article-title":"Causes of death in a contemporary adult congenital heart disease cohort","volume":"104","author":"Yu","year":"2018","journal-title":"Heart"},{"key":"2026012919022683600_suaf090-B23","first-page":"407","article-title":"Long-term follow-up of implantable cardioverter-defibrillators in adult congenital heart disease patients: indications and outcomes","volume":"19","author":"Santharam","year":"2017","journal-title":"Europace"},{"key":"2026012919022683600_suaf090-B24","doi-asserted-by":"crossref","first-page":"1612","DOI":"10.1161\/CIRCULATIONAHA.120.046745","article-title":"Long-term follow-up of patients with tetralogy of Fallot and implantable cardioverter defibrillator: the DAI-T4F nationwide registry","volume":"142","author":"Waldmann","year":"2020","journal-title":"Circulation"},{"key":"2026012919022683600_suaf090-B25","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1111\/pace.13974","article-title":"Defibrillators in adult congenital heart disease: long-term risk of appropriate shocks, inappropriate shocks, and complications","volume":"43","author":"Moore","year":"2020","journal-title":"Pacing Clin Electrophysiol"},{"key":"2026012919022683600_suaf090-B26","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1046\/j.1540-8167.2004.03388.x","article-title":"Implications of implantable cardioverter defibrillator therapy in congenital heart disease and pediatrics","volume":"15","author":"Alexander","year":"2004","journal-title":"J Cardiovasc Electrophysiol"},{"key":"2026012919022683600_suaf090-B27","first-page":"236","article-title":"Incidence and clinical predictors of early and late complications of implantable cardioverter-defibrillators in adults with congenital heart disease","volume":"39","author":"Albertini","year":"2023","journal-title":"Can J Cardiol"},{"key":"2026012919022683600_suaf090-B28","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.1093\/eurheartj\/ehv735","article-title":"Implantable cardioverter-defibrillators in adults with congenital heart disease: a systematic review and meta-analysis","volume":"37","author":"Vehmeijer","year":"2016","journal-title":"Eur Heart J"},{"key":"2026012919022683600_suaf090-B29","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1016\/S0735-1097(97)00529-9","article-title":"High failure rate for an epicardial implantable cardioverter-defibrillator lead: implications for long-term follow-up of patients with an implantable cardioverter-defibrillator","volume":"31","author":"Brady","year":"1998","journal-title":"J Am Coll Cardiol"},{"key":"2026012919022683600_suaf090-B30","first-page":"100491","article-title":"Atrial arrhythmia predicts late events and mortality in patients with D-transposition of the great arteries and atrial switch repair","volume":"15","author":"Chiriac","year":"2024","journal-title":"Int J Cardiol Congenit Heart Dis"},{"key":"2026012919022683600_suaf090-B31","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1016\/j.jacc.2023.05.057","article-title":"Subcutaneous implantable cardioverter-defibrillators in patients with congenital heart disease","volume":"82","author":"Waldmann","year":"2023","journal-title":"J Am Coll Cardiol"},{"key":"2026012919022683600_suaf090-B32","doi-asserted-by":"crossref","first-page":"1966","DOI":"10.1093\/europace\/euy139","article-title":"Subcutaneous implantable cardioverter-defibrillator: is it ready for use in children and young adults? A single-centre study","volume":"20","author":"Silvetti","year":"2018","journal-title":"Europace"},{"key":"2026012919022683600_suaf090-B33","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1007\/s10840-021-00966-4","article-title":"Subcutaneous implantable cardioverter defibrillator in children and adolescents: results from the S-ICD \u201cMonaldi care\u201d registry","volume":"63","author":"Sarubbi","year":"2022","journal-title":"J Interv Card Electrophysiol"},{"key":"2026012919022683600_suaf090-B34","first-page":"100091","article-title":"Subcutaneous implantable cardioverter defibrillator in complex adult congenital heart disease. Results from the S-ICD \u201cMonaldi care\u201d registry","volume":"3","author":"Sarubbi","year":"2021","journal-title":"Int Journal of Cardiol CHD"},{"key":"2026012919022683600_suaf090-B35","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1007\/s10840-023-01670-1","article-title":"Combined subcutaneous implantable cardioverter defibrillator and pacemaker devices in complex congenital heart disease: a single-center experienced based study","volume":"68","author":"Sarubbi","year":"2025","journal-title":"J Interv Card Electrophysiol"},{"key":"2026012919022683600_suaf090-B36","doi-asserted-by":"crossref","first-page":"1292","DOI":"10.1056\/NEJMoa2206485","article-title":"Efficacy and safety of an extravascular implantable cardioverter-defibrillator","volume":"387","author":"Friedman","year":"2022","journal-title":"N Engl J Med"},{"key":"2026012919022683600_suaf090-B37","doi-asserted-by":"crossref","first-page":"1613","DOI":"10.1161\/CIRCULATIONAHA.115.015677","article-title":"Use of the wearable cardioverter defibrillator in high-risk cardiac patients: data from the prospective registry of patients using the wearable cardioverter defibrillator (WEARIT-II registry)","volume":"132","author":"Kutyifa","year":"2015","journal-title":"Circulation"},{"key":"2026012919022683600_suaf090-B38","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1056\/NEJMoa1800781","article-title":"Wearable cardioverter-defibrillator after myocardial infarction","volume":"379","author":"Olgin","year":"2018","journal-title":"N Engl J Med"},{"key":"2026012919022683600_suaf090-B39","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.ipej.2022.06.005","article-title":"Wearable cardioverter-defibrillator (life-vest): a feasible bridging treatment in adult congenital heart disease","volume":"22","author":"Sarubbi","year":"2022","journal-title":"Indian Pacing Electrophysiol J"},{"key":"2026012919022683600_suaf090-B40","doi-asserted-by":"crossref","first-page":"e102","DOI":"10.1016\/j.hrthm.2014.05.009","article-title":"PACES\/HRS expert consensus statement on the recognition and management of arrhythmias in adult congenital heart disease: developed in partnership between the Pediatric and Congenital Electrophysiology Society (PACES) and the Heart Rhythm Society (HRS). endorsed by the governing bodies of PACES, HRS, the American College of Cardiology (ACC), the American Heart Association (AHA), the European Heart Rhythm Association (EHRA), the Canadian Heart Rhythm Society (CHRS), and the International Society for Adult Congenital Heart Disease (ISACHD)","volume":"11","author":"Khairy","year":"2014","journal-title":"Heart Rhythm"},{"key":"2026012919022683600_suaf090-B41","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1161\/CIRCEP.113.000450","article-title":"Characterization of anatomic ventricular tachycardia isthmus pathology after surgical repair of tetralogy of Fallot","volume":"6","author":"Moore","year":"2013","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"2026012919022683600_suaf090-B42","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1016\/j.ccep.2022.06.008","article-title":"Ventricular tachycardia ablation in adult congenital heart disease","volume":"14","author":"Wallet","year":"2022","journal-title":"Card Electrophysiol Clin"},{"key":"2026012919022683600_suaf090-B43","doi-asserted-by":"crossref","first-page":"1108","DOI":"10.1016\/j.jacc.2023.06.034","article-title":"Ventricular arrhythmias in adults with congenital heart disease, part I: JACC state-of-the-art review","volume":"82","author":"Bessi\u00e8re","year":"2023","journal-title":"J Am Coll Cardiol"},{"key":"2026012919022683600_suaf090-B44","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.ijcard.2017.02.151","article-title":"Pacing in congenital heart disease\u2014a four-decade experience in a single tertiary centre","volume":"241","author":"Midha","year":"2017","journal-title":"Int J Cardiol"},{"key":"2026012919022683600_suaf090-B45","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1016\/j.jacc.2008.02.032","article-title":"ACC\/AHA\/HRS 2008 guidelines for device-based therapy of cardiac rhythm abnormalities: a report of the American College of Cardiology\/American Heart Association task force on practice guidelines (Writing Committee to Revise the ACC\/AHA\/NASPE 2002 guideline update for implantation of cardiac pacemakers and antiarrhythmia devices) developed in collaboration with the American Association for Thoracic Surgery and Society of Thoracic Surgeons","volume":"51","author":"Epstein","year":"2008","journal-title":"J Am Coll Cardiol"},{"key":"2026012919022683600_suaf090-B46","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1001\/jamacardio.2024.0689","article-title":"Fontan junctional rhythm-innocent bystander or silent killer?","volume":"9","author":"Balaji","year":"2024","journal-title":"JAMA Cardiol"},{"key":"2026012919022683600_suaf090-B47","doi-asserted-by":"crossref","first-page":"ytae506","DOI":"10.1093\/ehjcr\/ytae506","article-title":"Dual-chamber leadless pacemaker in complex adult congenital heart disease: a case report","volume":"8","author":"Ngan","year":"2024","journal-title":"Eur Heart J Case Rep"},{"key":"2026012919022683600_suaf090-B48","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.ipej.2024.03.002","article-title":"The leadless pacemaker in ACHD\u2014cautiously optimistic","volume":"24","author":"Kakarla","year":"2024","journal-title":"Indian Pacing Electrophysiol J"}],"container-title":["European Heart Journal Supplements"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/eurheartjsupp\/article-pdf\/28\/Supplement_1\/i25\/66632083\/suaf090.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/eurheartjsupp\/article-pdf\/28\/Supplement_1\/i25\/66632083\/suaf090.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,30]],"date-time":"2026-01-30T00:02:42Z","timestamp":1769731362000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/eurheartjsupp\/article\/28\/Supplement_1\/i25\/8444691"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1]]},"references-count":48,"journal-issue":{"issue":"Supplement_1","published-online":{"date-parts":[[2026,1,30]]},"published-print":{"date-parts":[[2026,1,30]]}},"URL":"https:\/\/doi.org\/10.1093\/eurheartjsupp\/suaf090","relation":{},"ISSN":["1520-765X","1554-2815"],"issn-type":[{"value":"1520-765X","type":"print"},{"value":"1554-2815","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026,1]]},"published":{"date-parts":[[2026,1]]}}}